IVOG
Vanguard S&P Mid-Cap 400 Growth ETF
Vanguard S&P Mid-Cap 400 Growth ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the S&P Mid-Cap 400 Growth Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.7 B
ASSETS UNDER MGMT
10 bp
EXPENSES
Fund Basics
| Inception date | Sep 07, 2010 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Delayed |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| TWILIO, INC. CLASS A | 1.9 % |
| TECHNIPFMC PLC | 1.7 % |
| PURE STORAGE, INC. CLASS A | 1.7 % |
| ALLEGHENY TECHNOLOGIES INC | 1.6 % |
| OKTA, INC. CLASS A | 1.6 % |
| NVENT ELECTRIC PLC | 1.4 % |
| TENET HEALTHCARE CORP | 1.2 % |
| XPO LOGISTICS INC | 1.2 % |
| COEUR D'ALENE MINES CORP | 1.2 % |
| ROYAL GOLD INC | 1.2 % |
Constituent Breakdown
| Number of holdings | 252 |
| Herfindahl-Hirschman Index | 68 |
| Wgt avg mkt cap (mns) | $13,960 |
| Large cap (>$10bn) | 65.9% |
| Mid cap ($2-10bn) | 29.9% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 95.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 89.4 % |
 |
BRITAIN | 3.9 % |
 |
IRELAND | 0.8 % |
 |
CAYMAN ISLANDS | 0.8 % |
 |
BERMUDA | 0.7 % |
Historical Performance
Standardized Performance (as of 08/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 17.3% | 19.2% | 11.5% | 14.1% | 6.5% | 9.9% | -- | 11.4% |
| Dividend Yield | 0.0% | 0.8% | 0.8% | 1.0% | 0.9% | 1.0% | -- | 0.9% |
| Total Returns | 17.3% | 20.0% | 12.3% | 15.0% | 7.4% | 10.9% | -- | 12.3% | Ann. Volatility | 18.9% | 17.9% | 20.2% | 19.1% | 20.8% | 20.7% | -- | 19.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.15 | 67% |
| MSCI EAFE | 0.87 | 57% |
| MSCI Emg Mkts | 0.53 | 54% |
Liquidity Measures
| Avg. volume (000) | 24 |
| ADV traded (mns) | $3 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.27% |
Technical Indicators
| 30d moving avg. (EMA) | $143.29 |
| Relative strength (RSI) | 61 |
| MACD/Signal | 1.62/0.86 |
| Bollinger Bands (Upper/Lower) | $149.09/$136.52 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. IVOG |
Expenses vs. IVOG |
ALTAR Score™ vs. IVOG |
|---|---|---|---|---|
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 95.5% | +7 bp | 0.0% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 95.4% | +5 bp | 0.0% |
| MDY | SPDR S&P Midcap 400 ETF Trust | 65.2% | +13 bp | +1.7% |
| IJH | iShares Core S&P Mid-Cap ETF | 63.1% | -5 bp | +1.8% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 63.0% | -7 bp | +1.8% |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 62.6% | -3 bp | +1.8% |
| XJH | iShares ESG Screened S&P Mid-Cap ETF | 62.6% | +2 bp | +1.7% |
| QVMM | Invesco S&P MidCap 400 QVM Multi-factor ETF | 55.3% | +5 bp | +1.8% |
| RFG | Invesco S&P Midcap 400 Pure Growth ETF | 50.2% | +25 bp | +0.9% |
| MIDE | Xtrackers S&P MidCap 400 ESG ETF | 46.6% | +5 bp | +2.5% |
Risk and Returns: IVOG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 9/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.0%
ALTAR SCORE™
44th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,408 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. IVOG's ALTAR Score™ is approximately -0.1 standard
deviations above the category average. This places IVOG in the 44th percentile
among funds in the category.
Sell-Side Consensus
$158.06
PRICE TARGET
+11.8%
UPSIDE